Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

Background: Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. Some epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutations make tumours responsive to treatment with EGFR-TK inhibitors (EGFR-TKIs) but less responsive to treatment with standard chemotherapy. Patie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Marie Westwood, Manuela Joore, Penny Whiting, Thea van Asselt, Bram Ramaekers, Nigel Armstrong, Kate Misso, Johan Severens, Jos Kleijnen
Format: Artigo
Idioma:Inglês
Publicat: NIHR Journals Library 2014-05-01
Col·lecció:Health Technology Assessment
Matèries:
epidermal growth factor receptor tyrosine kinase
mutation
testing
non-small-cell lung cancer
metastasis
systematic review
cost-effectiveness
Accés en línia:https://doi.org/10.3310/hta18320
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars